141 results
Page 4 of 8
424B5
ryyur e2t
21 Feb 20
Prospectus supplement for primary offering
4:26pm
424B5
ra0otw0gmbv32ovuc
20 Feb 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
vu1iq16 0fn2t2r
18 Feb 20
Regulation FD Disclosure
8:50am
8-K
EX-10.1
dv8irlpw
12 Feb 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
sugz f202t
8 Jan 20
Results of Operations and Financial Condition
4:31pm
8-K
EX-1.1
xyeqc xxphcnep8hw6cv
8 Nov 19
Entry into a Material Definitive Agreement
4:38pm
424B5
99h6u vi23d4bcsa
8 Nov 19
Prospectus supplement for primary offering
4:34pm
8-K
EX-99.1
c6ddfvnjgv1hhtt1
28 Oct 19
Agile Therapeutics Reports Third Quarter 2019 Financial Results
8:10am
8-K
EX-1.1
od7zk qiaw04qdrt
2 Aug 19
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:50pm
424B5
hm4m14gwl
2 Aug 19
Prospectus supplement for primary offering
4:40pm
424B5
zzmjt f2ndprpiqb5
1 Aug 19
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.1
jfm2ksq4o j4
1 Aug 19
Agile Therapeutics Reports Second Quarter 2019 Financial Results
8:14am
8-K
EX-99.1
k3rjzq9ljk8l30
28 Jun 19
Other Events
8:00am
8-K
40h0w6gw
28 Jun 19
Other Events
8:00am
8-K
k9h26ak kudxo6r7o
6 May 19
Other Events
4:29pm
8-K
EX-99.1
dkq2xbnw5 1e9kkw
6 May 19
Other Events
4:29pm